Neuroleptic malignant syndrome

MONDO:0019790

Neuroleptic malignant syndrome (NMS) is an idiosyncratic condition associated with administration of antipsychotic and other central dopaminergic blockers, and characterized by hyperthermia, muscular rigidity, autonomic dysfunction and altered consciousness.

Also known as: NMS

1 clinical trial for this condition and its sub-types, 1 tagged with Neuroleptic malignant syndrome itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Nervous system disorder (26588) ↑ Syndromic disease (7133)

Including sub-types (1) Tagged with Neuroleptic malignant syndrome (1)

Trials to join now! 1

New pill shows promise for tough lung cancers

Disease control Recruiting now

This study tests an experimental drug, atamparib, in 178 adults with advanced or metastatic non-small cell lung cancer (a common type of lung cancer) that has not responded to standard treatments. The trial has two parts: first, finding the safest dose, then checking how well it …

Phase 1/2 • Sponsor: Nerviano Medical Sciences (Shanghai) Ltd. • Aim: Disease control

Last updated Jul 31, 2026 00:00 UTC

Neuroleptic malignant syndrome

Where it sits in the disease tree

New pill shows promise for tough lung cancers